Vaxart, Inc.
VXRT
$0.4472
$0.046511.61%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 207.82% | -22.93% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 207.82% | -22.93% | |||
| Cost of Revenue | 50.37% | -13.81% | |||
| Gross Profit | 26.29% | 8.54% | |||
| SG&A Expenses | -7.35% | -16.13% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 37.45% | -14.34% | |||
| Operating Income | 20.61% | 10.96% | |||
| Income Before Tax | 16.02% | 14.49% | |||
| Income Tax Expenses | 877.78% | -14.29% | |||
| Earnings from Continuing Operations | 14.88% | 14.49% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 14.88% | 14.49% | |||
| EBIT | 20.61% | 10.96% | |||
| EBITDA | 24.45% | 12.76% | |||
| EPS Basic | 14.86% | 30.53% | |||
| Normalized Basic EPS | 16.06% | 30.58% | |||
| EPS Diluted | 14.86% | 31.22% | |||
| Normalized Diluted EPS | 16.06% | 30.58% | |||
| Average Basic Shares Outstanding | 0.06% | 23.15% | |||
| Average Diluted Shares Outstanding | 0.06% | 23.15% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||